TrialRheumatology (Oxford, England)2008

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort.

S Durán-Barragán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.